MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN

Authors

  • Khojasteh SHARIFI-SARASIABI Hormozgan University of Medical Sciences; Molecular Medicine Research Center
  • Ali HAGHIGHI Shahid Beheshti University of Medical Sciences; School of Medicine; Department of Parasitology and Mycology
  • Bahram KAZEMI Shahid Beheshti University of Medical Sciences; Cellular and Molecular Biology Research Center
  • Niloofar TAGHIPOUR Shahid Beheshti University of Medical Sciences; School of Medicine; Department of Parasitology and Mycology
  • Ehsan Nazemalhosseini MOJARAD Shahid Beheshti University of Medical Sciences; Cellular and Molecular Biology Research Center
  • Latif GACHKAR Shahid Beheshti University of Medical Sciences; Infectious Diseases and Tropical Medicine Research Center

Abstract

In Iran, both Plasmodium vivax and P. falciparum malaria have been detected, but P. vivax is the predominant species. Point mutations in dihydrofolate reductase (dhfr) gene in both Plasmodia are the major mechanisms of pyrimethamine resistance. From April 2007 to June 2009, a total of 134 blood samples in two endemic areas of southern Iran were collected from patients infected with P. vivax and P. falciparum. The isolates were analyzed for P. vivax dihydrofolate reductase (pvdhfr) and P. falciparum dihydrofolate reductase (pfdhfr) point mutations using various PCR-based methods. The majority of the isolates (72.9%) had wild type amino acids at five codons of pvdhfr. Amongst mutant isolates, the most common pvdhfr alleles were double mutant in 58 and 117 amino acids (58R-117N). Triple mutation in 57, 58, and 117 amino acids (57L/58R/117N) was identified for the first time in the pvdhfr gene of Iranian P. vivax isolates. All the P. falciparumsamples analyzed (n = 16) possessed a double mutant pfdhfrallele (59R/108N) and retained a wild-type mutation at position 51. This may be attributed to the fact that the falciparum malaria patients were treated using sulfadoxine-pyrimethamine (SP) in Iran. The presence of mutant haplotypes in P. vivax is worrying, but has not yet reached an alarming threshold regarding drugs such as SP. The results of this study reinforce the importance of performing a molecular surveillance by means of a continuous chemoresistance assessment.

Downloads

Download data is not yet available.

Downloads

Published

2016-01-01

Issue

Section

Original Articles

How to Cite

SHARIFI-SARASIABI, K., HAGHIGHI, A., KAZEMI, B., TAGHIPOUR, N., MOJARAD, E. N., & GACHKAR, L. (2016). MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN . Revista Do Instituto De Medicina Tropical De São Paulo, 58, e16-. https://www.revistas.usp.br/rimtsp/article/view/113159